Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice

Journal of Controlled Release

Volumn 136, Issue 1, 2009, Pages 71-78

  Ding, Z ^a,d   Verbaan, F J ^a   Bivas Benita, M ^a   Bungener, L ^b   Huckriede, A ^b   van den Berg, D J ^a   Kersten, G ^c   Bouwstra, J A ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^d NANJING UNIVERSITY   (China)

Author keywords

Antibody response; Diphtheria toxoid; Influenza vaccine; Microneedle array; Transcutaneous immunization

Indexed keywords

ANTIBODY RESPONSE; DIPHTHERIA TOXOID; INFLUENZA VACCINE; MICRONEEDLE ARRAY; TRANSCUTANEOUS IMMUNIZATION;

ANTIBODIES; CHEMICAL WATER TREATMENT; ELECTRIC LOSSES; IMMUNIZATION; IMMUNOLOGY; POTENTIOMETRIC SENSORS; SKIN; SULFATE MINERALS; SUPRAMOLECULAR CHEMISTRY;

VACCINES;

ALUMINUM PHOSPHATE; ALUMINUM POTASSIUM SULFATE; CHOLERA TOXIN; DIPHTHERIA TOXOID; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DIPHTHERIA; DRUG TRANSPORT; FEMALE; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; MICRONEEDLE ARRAY; MOUSE; NEEDLE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHOLERA TOXIN; DIPHTHERIA; DIPHTHERIA TOXOID; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C;

EID: 67349252458     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.01.025     Document Type: Article

References (38)

1. Glenn G.M., and Kenney R.T. Mass vaccination: solutions in the skin. Curr. Top. Microbiol. Immunol. 304 (2006) 247-268
2. Glenn G.M., Kenney R.T., Hammond S.A., and Ellingsworth L.R. Transcutaneous immunization and immunostimulant strategies. Immunol. Allergy Clin. North Am. 23 4 (2003) 787-813
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
4. Kenney R.T., Yu J., Guebre-Xabier M., Frech S.A., Lambert A., Heller B.A., Ellingsworth L.R., Eyles J.E., Williamson E.D., and Glenn G.M. Induction of protective immunity against lethal anthrax challenge with a patch. J. Infect. Dis. 190 4 (2004) 774-782
5. Chen D., Burger M., Chu Q., Endres R., Zuleger C., Dean H., and Payne L.G. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res. 103 1-2 (2004) 147-153
6. Gupta P.N., Mishra V., Singh P., Rawat A., Dubey P., Mahor S., and Vyas S.P. Tetanus toxoid-loaded transfersomes for topical immunization. J. Pharm. Pharmacol. 57 3 (2005) 295-301
7. Tierney R., Beignon A.S., Rappuoli R., Muller S., Sesardic D., and Partidos C.D. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses. J. Infect. Dis. 188 5 (2003) 753-758
8. Garg S., Hoelscher M., Belser J.A., Wang C., Jayashankar L., Guo Z., Durland R.H., Katz J.M., and Sambhara S. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin. Vaccine Immunol. 14 7 (2007) 926-928
9. Glenn G.M., Flyer D.C., Ellingsworth L.R., Frech S.A., Frerichs D.M., Seid R.C., and Yu J. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert. Rev. Vaccines 6 5 (2007) 809-819
10. Zhao Y.L., Murthy S.N., Manjili M.H., Guan L.J., Sen A., and Hui S.W. Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 24 9 (2006) 1282-1290
11. Ogura M., Paliwal S., and Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv. Drug Deliv. Rev. 60 10 (2008) 1218-1223
12. Frech S.A., DuPont H.L., Bourgeois A.L., McKenzie R., Belkind-Gerson J., Figueroa J.F., Okhuysen P.C., Guerrero N.H., Martinez-Sandoval F.G., Melendez-Romero J.H.M., Jiang Z.D., Asturias E.J., Halpern J., Torres O.R., Hoffman A.S., Villar C.P., Kassem R.N., Flyer D.C., Andersen B.H., Kazempour K., Breisch S.A., and Glenn G.M. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 371 9629 (2008) 2019-2025
13. M.S. Gerstel, V.A. Place, Drug delivery device, U.S. Pat. 3,964,4821976.
14. Henry S., McAllister D.V., Allen M.G., and Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 88 9 (1999) 948
15. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 5 (2004) 581-587
16. Mikszta J.A., Dekker III J.P., Harvey G., Dean C.H., Brittingham J.M., Huang J., Sullivan V.J., Dyas B., Roy C.J., and Ulrich R.G. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect. Immun. 74 12 (2006) 6806-6810
17. Widera G., Johnson J., Kim L., Libiran L., Nyam K., Daddona P.E., and Cormier M. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24 10 (2006) 1653-1664
18. Verbaan F.J., Bal S.M., van den Berg D.J., Groenink W.H., Verpoorten H., Luttge R., and Bouwstra J.A. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 117 2 (2007) 238-245
19. Verbaan F.J., Bal S.M., van den Berg D.J., Dijksman J.A., van Hecke M., Verpoorten H., van den Berg A., Luttge R., and Bouwstra J.A. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J. Control. Release 128 1 (2008) 80-88
20. Scharton-Kersten T., Glenn G.M., Vassell R., Yu J., Walwender D., and Alving C.R. Principles of transcutaneous immunization using cholera toxin as an adjuvant. Vaccine 17 Suppl 2 (1999) S37-43
21. Scharton-Kersten T., Yu J., Vassell R., O'Hagan D., Alving C.R., and Glenn G.M. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immun. 68 9 (2000) 5306-5313
22. Upadhyay P. Enhanced transdermal-immunization with diphtheria-toxoid using local hyperthermia. Vaccine 24 27-28 (2006) 5593-5598
23. Metz B., Jiskoot W., Hennink W.E., Crommelin D.J., and Kersten G.F. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 22 2 (2003) 156-167
24. Miyamura K., Tajiri E., Ito A., Murata R., and Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J. Biol. Stand. 2 3 (1974) 203-209
25. de Haan L., Verweij W.R., Holtrop M., Brands R., van Scharrenburg G.J., Palache A.M., Agsteribbe E., and Wilschut J. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine 19 20-22 (2001) 2898-2907
26. Verweij W.R., de Haan L., Holtrop M., Agsteribbe E., Brands R., van Scharrenburg G.J., and Wilschut J. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16 20 (1998) 2069-2076
27. WHO. Collaborating center for influenza viruses. Version 31 (1981)
28. Mikszta J.A., Sullivan V.J., Dean C., Waterston A.M., Alarcon J.B., Dekker III J.P., Brittingham J.M., Huang J., Hwang C.R., Ferriter M., Jiang G., Mar K., Saikh K.U., Stiles B.G., Roy C.J., Ulrich R.G., and Harvey N.G. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis. 191 2 (2005) 278-288
29. Mikszta J.A., Alarcon J.B., Brittingham J.M., Sutter D.E., Pettis R.J., and Harvey N.G. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8 4 (2002) 415-419
30. Dean C.H., Alarcon J.B., Waterston A.M., Draper K., Early R., Guirakhoo F., Monath T.P., and Mikszta J.A. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum. Vaccin 1 3 (2005) 106-111
31. Bal S.M., Caussin J., Pavel S., and Bouwstra J.A. In vivo assessment of safety of microneedle arrays in human skin. Eur. J. Pharm. Sci. (2008)
32. Skountzou I., Quan F.S., Jacob J., Compans R.W., and Kang S.M. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24 35-36 (2006) 6110-6119
33. Godefroy S., Peyre M., Garcia N., Muller S., Sesardic D., and Partidos C.D. Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin. Infect. Immun. 73 8 (2005) 4803-4809
34. Frech S.A., Kenney R.T., Spyr C.A., Lazar H., Viret J.F., Herzog C., Gluck R., and Glenn G.M. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23 7 (2005) 946-950
35. Glenn G.M., Rao M., Matyas G.R., and Alving C.R. Skin immunization made possible by cholera toxin. Nature 391 6670 (1998) 851
36. Bos J.D., and Meinardi M.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9 3 (2000) 165-169
37. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., and Blume-Peytavi0 U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 123 1 (2004) 168-176
38. Vogt A., Combadiere B., Hadam S., Stieler K.M., Lademann J., Schaefer H., Autran B., Sterry W., and Blume-Peytavi U. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J. Invest. Dermatol. 126 6 (2006) 1316-1322